Stay updated on CAR.NK Cells for B-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the CAR.NK Cells for B-cell Lymphoma Clinical Trial page.

Latest updates to the CAR.NK Cells for B-cell Lymphoma Clinical Trial page
- Check5 days agoChange DetectedThe page displays the ClinicalTrials.gov record for a CAR-NK cell, chemotherapy, and stem-cell transplant study for B-cell lymphoma, marked withdrawn due to lack of funding. It includes the study’s eligibility criteria, treatment plan, and measured outcomes.SummaryDifference79%

- Check12 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check26 days agoChange DetectedAn NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study content and navigation with a standard error screen. The embedded HTML and '403' indicator show an access restriction rather than an update to the study record.SummaryDifference23%

- Check61 days agoChange DetectedThe page revision tag has been updated from v3.6.6 to v3.7.0, indicating a deployment of the page. Substantive study details appear unchanged.SummaryDifference0.0%

Stay in the know with updates to CAR.NK Cells for B-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR.NK Cells for B-cell Lymphoma Clinical Trial page.